z-logo
Premium
Benign pathological findings in 303 Chinese patients undergoing surgery for presumed localized renal cell carcinoma
Author(s) -
Xiong YongHong,
Zhang ZhiLing,
Li YongHong,
Liu ZhuoWei,
Hou GuoLiang,
Liu Qing,
Yun JingPing,
Zhang XueQi,
Zhou FangJian
Publication year - 2010
Publication title -
international journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.172
H-Index - 67
eISSN - 1442-2042
pISSN - 0919-8172
DOI - 10.1111/j.1442-2042.2010.02525.x
Subject(s) - medicine , renal cell carcinoma , nephrectomy , pathological , incidence (geometry) , kidney , carcinoma , radiology , urology , pathology , physics , optics
Objective:  To analyze the incidence of benign lesions in Chinese patients undergoing nephrectomies for renal masses identified as localized renal cell carcinoma (RCC) in preoperative imaging. Methods:  Between 1999 and 2007, 303 patients (112 female, 191 male) with presumed localized RCC underwent nephrectomy (234 radical nephrectomies and 69 partial nephrectomies). Preoperative computed tomography images and pathological findings were reviewed and analyzed. Results:  Pathological examinations revealed 31 (10.2%) benign lesions in the 303 patients. Among these 31 benign lesions, 15 (5.0%) were angiomyolipomas (AML) and only four (1.3%) were oncocytomas. Significantly, 20 (17.9%) of the 112 female patients had benign lesions compared with 11 (5.8%; P  = 0.001) male patients. Benign renal lesions were found in five (25.0%) of the 20 patients with renal masses smaller than 2 cm, 13 (13.0%) of the 100 patients with renal masses 2–4 cm in size and 13 (7.1%) of the 183 patients with renal masses larger than 4 cm. Conclusions:  Patients in the present study population show a low incidence of benign renal lesions, approximately half of them being AML. Female patients and patients with renal masses smaller than 4 cm are more likely to have benign renal lesions.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here